$4.02
2.90% yesterday
Nasdaq, Oct 15, 10:18 pm CET
ISIN
US38246G1085
Symbol
GDRX

GoodRx Holdings Stock price

$4.02
-0.06 1.47% 1M
-0.47 10.47% 6M
-0.63 13.55% YTD
-2.94 42.24% 1Y
-0.72 15.19% 3Y
-47.54 92.20% 5Y
-28.98 87.82% 10Y
-28.98 87.82% 20Y
Nasdaq, Closing price Wed, Oct 15 2025
-0.12 2.90%

Key metrics

Basic
Market capitalization
$1.4b
Enterprise Value
$1.6b
Net debt
$208.7m
Cash
$281.3m
Shares outstanding
352.8m
Valuation (TTM | estimate)
P/E
46.0 | 10.9
P/S
1.8 | 1.8
EV/Sales
2.1 | 2.0
EV/FCF
13.9
P/B
2.2
Financial Health
Equity Ratio
52.2%
Return on Equity
2.3%
ROCE
7.1%
ROIC
5.3%
Debt/Equity
0.8
Financials (TTM | estimate)
Revenue
$799.9m | $814.7m
EBITDA
$161.3m | $271.2m
EBIT
$84.0m | $205.8m
Net Income
$34.6m | $134.5m
Free Cash Flow
$118.4m
Growth (TTM | estimate)
Revenue
3.2% | 2.8%
EBITDA
99.7% | 100.3%
EBIT
391.5% | 212.5%
Net Income
159.0% | 720.7%
Free Cash Flow
86.3%
Margin (TTM | estimate)
Gross
93.7%
EBITDA
20.2% | 33.3%
EBIT
10.5%
Net
4.3% | 16.5%
Free Cash Flow
14.8%
More
EPS
$0.1
FCF per Share
$0.3
Short interest
7.2%
Employees
738
Rev per Employee
$1.1m
Show more

Is GoodRx Holdings a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

GoodRx Holdings Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a GoodRx Holdings forecast:

13x Buy
62%
7x Hold
33%
1x Sell
5%

Analyst Opinions

21 Analysts have issued a GoodRx Holdings forecast:

Buy
62%
Hold
33%
Sell
5%

Financial data from GoodRx Holdings

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
800 800
3% 3%
100%
- Direct Costs 51 51
13% 13%
6%
749 749
5% 5%
94%
- Selling and Administrative Expenses 460 460
8% 8%
58%
- Research and Development Expense 123 123
8% 8%
15%
161 161
100% 100%
20%
- Depreciation and Amortization 77 77
30% 30%
10%
EBIT (Operating Income) EBIT 84 84
391% 391%
11%
Net Profit 35 35
159% 159%
4%

In millions USD.

Don't miss a Thing! We will send you all news about GoodRx Holdings directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

GoodRx Holdings Stock News

Neutral
Business Wire
about 15 hours ago
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the launch of a new subscription for hair loss treatment. Built for simplicity and transparency, GoodRx for Hair Loss helps men access affordable treatments that are clinically proven to slow hair loss and support regrowth. Hair loss is one of the most common he...
Positive
Seeking Alpha
5 days ago
GoodRx is leveraging partnerships with Novo Nordisk and potential TrumpRx involvement to offset stagnating user growth and drive higher-margin revenue. Despite a 14% decline in Monthly Active Consumers, GDRX improved average revenue per user and maintains high gross margins above 90%. Valuation appears modestly undervalued, with scenario analysis showing upside if collaborations materialize, bu...
Neutral
Reuters
6 days ago
Retail pharmacies and prescription drug savings site GoodRx are talking with the Trump administration about joining its TrumpRx website, they told Reuters, suggesting an expansion beyond the early description of it as a link to pharmaceutical companies' direct discounts.
More GoodRx Holdings News

Company Profile

GoodRx Holdings, Inc. operates a consumer-focused digital healthcare platform. The firm offers information and tools to help consumers compare prices for prescription drugs. It operates applications and websites that provide prices and discounts at local and mail-order pharmacies. The company was founded in September 2015 and is headquartered in Santa Monica, CA.

Head office United States
CEO Wendy Barnes
Employees 738
Founded 2015
Website investors.goodrx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today